Thursday, November 30, 2017

Mast Cell Activation in Brain Injury, Stress and Post-Traumatic Stress Disorder and Alzheimer’s Disease Pathogenesis

Mast Cell Activation in Brain Injury, Stress and Post-Traumatic Stress Disorder and Alzheimer’s Disease Pathogenesis: Mast cells are localized throughout the body and mediate allergic, immune and inflammatory reactions. They are heterogeneous, tissue-resident, long-lived and granulated cells. Mast cells increase their numbers in specific site in the body by proliferation, increased recruitment, increased survival and increased rate of maturation from its progenitors. Mast cells are implicated in brain injuries, neuropsychiatric disorders, stress, neuroinflammation and neurodegeneration. Brain mast cells are the first responders before microglia in the brain injuries since mast cells can release prestored mediators. Mast cells also can detect amyloid plaque formation during Alzheimer’s disease (AD) pathogenesis. Stress conditions activate mast cells to release prestored and newly synthesized inflammatory mediators and induce increased blood-brain barrier permeability, recruitment of immune and inflammatory cells into the brain and neuroinflammation. Stress induces the release of corticotropin-releasing hormone (CRH) from paraventricular nucleus of hypothalamus and mast cells. CRH activates glial cells and mast cells through CRH receptors and releases neuroinflammatory mediators. Stress also increases proinflammatory mediator release in the peripheral systems that can induce and augment neuroinflammation. Post-traumatic stress disorder (PTSD) is a traumatic-chronic stress related mental dysfunction. Currently there is no specific therapy to treat PTSD since its disease mechanisms are not ye...

No comments: